Brief: Nuvation Bio Announces Acquisition Of Japan Rights To Safusidenib From Daiichi Sankyo
01/04/2026 14:11
April 1 (Reuters) - Koge Micro Tech Co Ltd 4568.TWO: NUVATION BIO ANNOUNCES ACQUISITION OF JAPAN RIGHTS TO SAFUSIDENIB FROM DAIICHI SANKYO NUVATION BIO INC - BUYS JAPAN RIGHTS TO SAFUSIDENIB FROM DAIICHI SANKYO NUVATION BIO INC - GAINS OWNERSHIP OF GLOBAL CLINICAL DEVELOPMENT PROGRAM FOR SAFUSIDENIB NUVATION BIO INC - TO EXPAND PIVOTAL SIGMA STUDY OF SAFUSIDENIB INTO JAPAN Source text: ID:nPn25pYNSa Further company coverage: 4568.TWO ((Reuters.Briefs@thomsonreuters.com;))